Indeed, vascular dysfunction has been demonstrated to contribute to AD pathogenesis and progression by impairing cerebral blood flow (CBF), exacerbating Aβ and tau pathologies, triggering neuronal death, and inducing glial cell activation (31–35). Here, MAPT is linked to Alzheimer disease.